Chanelle McCoy Health shares a passion for science innovation.
Chanelle, Lady McCoy and Caroline Glynn have worked together for 11 years in a global pharmaceutical company, where they developed the medical business, penetrating across 96 markets and achieving multiple medicines licences. Over the years they have built up superb regulatory expertise, operational & supply chain knowledge and an extensive pharmaceutical network.
As an R&D led company, Chanelle McCoy Health has spent five years, and a number of millions developing its Pureis® CBD food supplement product. It is the 1st CBD food supplement on the market that is clinically proven to be safe, and it is the 1st CBD food supplement on the market GLOBALLY using FDA registered raw material with 0% THC. Pureis® CBD is an Ultra Pure CBD.
For more details on Pureis® Ultra Pure CBD visit https://www.pureiscbd.com
For more details on Pureis® Ultra Pure CBD please visit https://www.pureiscbd.com
Chanelle McCoy Health has the capability to supply CBD under the Special Medicine Access Scheme. We can supply our products under pharmaceutical GMP conditions and have the necessary special licence.
Chanelle McCoy Health makes available unlicensed medicines to customers on the basis that they have a prescription for a CBD product and that there is a special clinical need for a particular formulation.
For more information please email info@chanellemccoyhealth.com
M.A., B.Sc. Management
Founder & CEO
Chanelle, Lady McCoy, MA, BSc Management, led Chanelle Medical – part of the multi-million-pound global company Chanelle Pharma, based in Galway, Ireland – for 18 years. The business is now Ireland’s largest indigenous pharma company, employing 550+.
Chanelle had responsibility for penetrating 96 markets and achieving multiple product licences. Having left to pursue other pharma opportunities, Chanelle is still a shareholder in Chanelle Pharma. She was awarded the All Ireland Business Champion Award 2018 for her outstanding achievements in business leadership; was a dragon investor on the TV series Dragons’ Den; and recently ranked “number 23 in the 50 incredible people shaping modern Ireland”
B.Sc., MSc., L.LM
Co-Founder & CSO
Caroline Glynn, BSc, MSc, LLM, qualified with a degree in Pharmacology, a master’s in Biomedical Science, and a master’s in Law. Her scientific and legal background complements in driving and growing pharmaceutical companies.
She held several senior global positions before taking the reins of Medical Commercial Director in Chanelle Pharma, with a focus on driving the scientific and commercial innovation needed to have a transformational growth in Chanelle Pharma human business, achieving year on year growth.
The essence of our values are looking after you with the safest, highest quality product; profit is secondary.
#You1stDollars2nd
We have invested financially and with love in multiple clinical trials to prove our product is absolute safe for you.
#MultipleClinicalTrials
We enjoy going above and beyond to earn your trust.
#EarnYourTrust
We have put ourselves in your shoes, and we really care.
#InYourShoes
Our consumers, suppliers, team…
#WeListenMoreThanWeSpeak
We have invested many years of research into breaking new ground in the world of CBD, supported by science.
#NewScience
Hearing about people struggling to access CBD, or having to leave their shores to get access to CBD in countries that had regulated its use, these stories really resonated with us.
In 2015, we started to research CBD, and this led us to set up Chanelle McCoy Health, an R&D-led pharmaceutical company. We knew there was an unmet need for a pure, safe, quality assured CBD product backed by clinical studies. This was where our journey began.
Quality is paramount in us delivering our promises to you. This is why all we offer are produced and manufactured under the stringent quality control procedures, all Good Manufacturing Practice (GMP) certified. GMP is a requirement for medicines and certified by each country regulatory authority. Our CBD products are produced in UK Medicines and Healthcare products Regulatory Agency (MHRA) and EU approved facilities, all operating under GMP conditions.
Our diagnostic devices comply to the quality standard of ISO 13485, pertaining to medical devices. All of our devices are CE marked in accordance with In vitro Diagnostic Medical Device Directive.
This means that you can have complete TRUST in our high quality, fully compliant products, supported by science. If you would like to receive more information, please contact our office on +353 87 962 6181.